Compound Detail
CHEMBL1366
AURANOFIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL1366 |
| Name | AURANOFIN |
| Phase | Approved |
| Structure Type | NONE |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
8
Known Names
14
Indications
1
Mechanisms
Molecular Properties
678.5
MW (Da)
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1985 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Unknown | - | - | ✓ | ✓ |
Indications
Arthritis, Rheumatoid Rheumatic Diseases Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Ovarian Neoplasms Pain Tuberculosis Adenocarcinoma of Lung Amebiasis Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Glioblastoma HIV Infections Small Cell Lung Carcinoma
ATC Classification
M01CB03
auranofin
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
Drug Warnings
Black Box Warning
hematological toxicity
Black Box Warning
gastrointestinal toxicity
Black Box Warning
nephrotoxicity
Black Box Warning
dermatological toxicity
Data from ChEMBL 36 via Core Engine